SESSION 41 SCHEDULE
Saturday
SESSION 41: NEW DEVELOPMENTS IN AAAS AND THEIR TREATMENT (5-MINUTE TALKS)
x
6:40 AM - 6:45 AM Impact Of A Redeployable AAA Stent-Graft (Gore Excluder C-3) To Improve Proximal Seal In Difficult Anatomy: Does It Make A Difference
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Abstract      
6:46 AM - 6:51 AM Is A Thick Layer Of Neck Thrombus A Contraindication For EVAR
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
6:52 AM - 6:57 AM Final Result Of The PEVAR Trial: A RCT Comparing Percutaneous With Open Access For EVAR
  Presenter(s):Zvonimir Krajcer, MD, FACC  
6:58 AM - 7:03 AM Open And Endovascular Repair Of Para-Anastomotic Aneurysms
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
  View Abstract      
7:04 AM - 7:09 AM Transecting The Left Renal Vein For Aortic Surgery: Why, How, When, Where And Why Not
  Presenter(s):Afshin Assadian, MD  
7:10 AM - 7:15 AM DEBATE: Laparoscopic Vascular Surgery Should Be Growing And Vascular Surgeons Should Learn It And Do It
  Presenter(s):Joseph S. Giglia, MD  
7:16 AM - 7:21 AM DEBATE: Why Laparoscopic And Robotic Aortic Surgery Are Losing Their Appeal And Will Not Become Widespread
  Presenter(s):Willem Wisselink, MD  
7:22 AM - 7:27 AM The Rise And Fall Of AAAs: The Decreasing Incidence Of AAAs: What Is The Cause
  Presenter(s):Frank A. Lederle, MD  
7:28 AM - 7:33 AM Is EVAR Indicated And Justified For Inflammatory AAAs: When Is It Not
  Presenter(s):Samuel R. Money, MD, MBA  
7:34 AM - 7:39 AM Is There A Role For AUI Endografts For EVAR In 2012: Should One Be In Your Endovascular Tool Box For Emergency Use
  Presenter(s):Thomas L. Forbes, MD  
  View Abstract      
7:40 AM - 7:45 AM Feasibility Of EVAR For Infected AAAs: When Does It Work And When Doesn’t It
  Presenter(s):Chung-Dann Kan, PhD  
7:46 AM - 7:51 AM How To Manage Infected Aortic Endografts
  Presenter(s):Edward Y. Woo, MD / Ronald M. Fairman, MD  
  View Abstract      
7:52 AM - 7:57 AM Long-Term Quality Of Life Data After EVAR And Open Repair: From The DREAM Trial: Open Repair Wins And Why
  Presenter(s):Jan D. Blankensteijn, MD  
7:58 AM - 8:03 AM The Vital Focus On EVAR vs. Open Repair At 15 Years: Is The Game Changing
  Presenter(s):Roger M. Greenhalgh, MD  
8:04 AM - 8:12 AM Panel Discussion
END OF SESSION 41
 
SESSION 42 SCHEDULE
Saturday
SESSION 42: NEW DEVELOPMENTS IN TREATMENT OF THE AORTA AND ITS BRANCHES (5-MINUTE TALKS)
x
8:13 AM - 8:18 AM How Does Transcatheter Intra-arterial Denervation Work: Who Should Be Treated And Who Should Not: Why Is The Artery Not Injured And Are There Dangers From The Treatment
  Presenter(s):Yvonne Bausback, MD / Dierk Scheinert, MD  
8:19 AM - 8:24 AM What Are The Secondary Benefits – Other Than Reducing Blood Pressure – To Renal Denervation: When Will This Treatment Be Available In The US And How Long Will All Benefits Last
  Presenter(s):Michael R. Jaff, DO / Ido Weinberg, MD, MSc  
8:25 AM - 8:30 AM Status Of Renal PTA And Stenting After ASTRAL And CORAL: What’s New In The Field
  Presenter(s):Thomas A. Sos, MD  
8:31 AM - 8:36 AM Frontiers In Renal Artery Stenting: What Does The Future Hold: Better Stents, Better Balloons, Etc.
  Presenter(s):Max Amor, MD  
8:37 AM - 8:42 AM Long-Term Outcomes Of PTA And/Or Stenting For Renal Fibromuscular Hyperplasia: What Is The Best Treatment
  Presenter(s):Albeir Y. Mousa, MD / Ali F. AbuRahma, MD  
8:43 AM - 8:48 AM Best Method To Assess SMA Stents: How Does Duplex Correlate With Pressure Measurements, CTA And Clinical Outcomes
  Presenter(s):Timothy A. Resch, MD, PhD  
8:49 AM - 8:54 AM Early And Late Outcomes Of PTA And Stenting Of Celiac And SMA Occlusive Disease: Advantages, Limitations And Results Up To 10 Years
  Presenter(s):Ali F. AbuRahma, MD  
  View Abstract      
8:55 AM - 9:00 AM Can The Results Of Mesenteric Revascularization Improve With Covered Stents And Distal Protection Devices
  Presenter(s):Gustavo S. Oderich, MD, FACS  
9:01 AM - 9:06 AM How To Treat Isolated SMA Dissections: When Medical vs. Interventional vs. Surgical Therapy
  Presenter(s):Young Wook Kim, MD  
  View Abstract      
9:07 AM - 9:13 AM Panel Discussion
Moderator(s): Enrico Ascher, MD / James C. Stanley, MD  
9:14 AM - 9:19 AM DEBATE: Treatment Of Mid-Aortic Syndrome In Young Adults: Interventional Treatment Is Indicated In Some
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
9:20 AM - 9:25 AM DEBATE: Interventional Therapy Is Never Indicated For Mid-Aortic Syndrome At Any Age: Open Surgery Is Best
  Presenter(s):Wilhelm Sandmann, MD  
9:26 AM - 9:31 AM When Are Reentry Devices And Covered Stents Needed For Iliac Occlusive Lesions
  Presenter(s):Jörn O. Balzer, MD, PhD  
9:32 AM - 9:37 AM DEBATE: Open Surgery Is Still Needed For Some Aortoiliac Occlusive Lesions: Which Ones
  Presenter(s):Michel S. Makaroun, MD  
9:38 AM - 9:43 AM DEBATE: Endovascular Treatment Is Best For All Aortoiliac Occlusive Lesions
  Presenter(s):Martin Malina, MD, PhD  
9:44 AM - 9:49 AM Endovascular Treatment Of Juxtarenal Aortic Occlusions Should Always Be Possible Using Chimneys And Other Adjuncts
  Presenter(s):Sonia Ronchey, MD / Nicola Mangialardi, MD  
9:50 AM - 9:55 AM Use Of Advanta V12 Covered Stents For Endovascular Reconstruction Of The Aortoiliac Bifurcation To Treat Complex Occlusive Lesions
  Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD  
  View Abstract      
9:56 AM - 10:20 AM Panel Discussion And Break
Visit Exhibits and Pavilions (2nd and 3rd Floors)

END OF SESSION 42
 
SESSION 43 SCHEDULE
Saturday
SESSION 43: FUTURE ISSUES REGARDING HEALTH CARE; CONFLICT OF INTEREST; GOVERNMENT; INDUSTRY RELATIONS; BUSINESS OF MEDICINE; PRACTICE COSTS; AND REIMBURSEMENTS (5-MINUTE TALKS)
x
10:20 AM - 10:25 AM How To Succeed With A Physician Founded Medical Device Company: The Embrella Device As An Example
  Presenter(s):Jeffrey P. Carpenter, MD  
10:26 AM - 10:31 AM Physician Focused Tort Reform By Limiting Expert MD Testimony Fees And Taking Other Accountability Measures: We Physicians Can Stop Medical Malpractice Abuses No Matter What The Damned Lawyers Do
  Presenter(s):O. William Brown, MD, JD  
  View Abstract      
10:32 AM - 10:37 AM What Will Health Care Reform Mean To Practicing Vascular Surgeons, Hospitals And Surgical Services
  Presenter(s):Robert M. Zwolak, MD, PhD  
10:38 AM - 10:43 AM What’s Happening With Vascular Reimbursement
  Presenter(s):Sean P. Roddy, MD  
10:44 AM - 10:49 AM What Is A Vascular Surgeon Worth To A Health Care System: A Look At The Finances Surrounding Vascular Care
  Presenter(s):Michael C. Stoner, MD  
  View Abstract      
10:50 AM - 10:55 AM Disclosure And Conflict Of Interest: Have We Gone Too Far Or Not Far Enough
  Presenter(s):Timothy M. Sullivan, MD  
10:56 AM - 11:01 AM Current Status Of The Physician-Industry Relationship: Update On What The Government, Our Medical Schools And Our Hospitals Are Doing To Separate Doctors From Industry
  Presenter(s):Barry T. Katzen, MD  
11:02 AM - 11:07 AM Physician-Industry Relationships And Conflict Of Interest: No Conflict – No Interest – No Success: How To Deal With The Pitfalls And Problems – Legally And Ethically
  Presenter(s):Scott L. Stevens, MD  
11:08 AM - 11:13 AM What Is Happening With The Physician-Industry Relationship In Community Practice
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
11:14 AM - 11:19 AM Cost Analysis Of Carotid Interventions In Asymptomatic Patients
  Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
11:20 AM - 11:25 AM Do Outcomes Of CEA Differ Among Different Specialties – Vascular Surgeons, General Surgeons And Neurosurgeons: Who Does The Best
  Presenter(s):Carlos H. Timaran, MD / Ali F. AbuRahma, MD  
11:26 AM - 11:31 AM What Has And Will The FDA Do To Medical Innovation In The US: An Innovator’s Perspective: Will Things Improve
  Presenter(s):Edward B. Diethrich, MD  
11:32 AM - 11:37 AM Panel Discussion
11:38 PM - 11:43 PM Poster Award Presentation
END OF SESSION 43
 
SESSION 44 SCHEDULE
Saturday
SESSION 44: TRIBUTE TO OUR MILITARY (5-MINUTE TALKS)
x
11:43 AM - 11:48 AM From The Front Lines To The Ivory Tower And Back: How Advances At Walter Reed National Military Medical Center Are Used At The Front
  Presenter(s):Robert Craig, DO  
11:49 AM - 11:54 AM A Brief History Of The Tourniquet In Battle
  Presenter(s):Norman M. Rich, MD, FACS, DMCC  
  View Abstract      
11:55 AM - 12:00 PM Vascular Surgery Lessons Learned After A Decade Of War In Iraq And Afghanistan
  Presenter(s):Todd E. Rasmussen, MD, FACS  
END OF SESSION 44
 
SESSION 45 SCHEDULE
Saturday
SESSION 45: LUNCHEON SESSION: NEW OR IMPROVED ENDOVASCULAR DEVICES (5-MINUTE TALKS)
x
12:01 PM - 12:06 PM Off-The-Shelf Fenestrated VENTANA Device For Renal Revascularization With Juxta And Pararenal AAAs: Clinical Update And Will In Situ Fenestration Be Possible With Newer Multilayer Stretchable PTFE Endograft Coverings
  Presenter(s):Daniel G. Clair, MD  
12:07 PM - 12:12 PM Recent Improvements In The Cook Zenith AAA Endograft: How Do They Make A Difference
  Presenter(s):Tara M. Mastracci, MD  
12:13 PM - 12:18 PM Update On Advantages And Limitations Of The Lombard AORFIX Graft: When Will It Be Approved In The US
  Presenter(s):Brian R. Hopkinson, ChM, FRCS / Mark F. Fillinger, MD  
  View Abstract      
12:19 PM - 12:24 PM Worldwide Experience With The Aptus HELIFX Endostaples: Can They Fix Endoleaks And Prevent Aortic Neck Enlargement And Migration
  Presenter(s):David H. Deaton, MD  
12:25 PM - 12:30 PM Update On The NELLIX Device For EVAR: Advantages And Limitations
  Presenter(s):Jeffrey P. Carpenter, MD  
12:31 PM - 12:36 PM Advantages And Limitations Of The INCRAFT From Cordis: 1-Year Clinical Data From The INNOVATION Trial
  Presenter(s):Gioacchino Coppi, MD / Dierk Scheinert, MD  
12:37 PM - 12:42 PM Description And Clinical Experience With The Anaconda Fenestrated Endograft For Juxta And Pararenal AAAs
  Presenter(s):Clark J. Zeebregts, MD, PhD  
12:43 PM - 12:48 PM Worldwide Mid-Term Results (2-Year) Of The Endurant Endograft For AAAs: Does It Expand The Proportion Of Patients Who Can Undergo EVAR Safely And Effectively
  Presenter(s):Dittmar Boeckler, MD / Michel S. Makaroun, MD  
12:49 PM - 12:54 PM Current Status Of The Bolton TREOVANCE AAA Endograft: Advantages And Limitations
  Presenter(s):Edward Y. Woo, MD / Ronald M. Fairman, MD  
12:55 PM - 1:00 PM Panel Discussion
END OF SESSION 45
 
SESSION 46 SCHEDULE
Saturday
SESSION 46: ISSUES RELATED TO TRAINING, CERTIFICATION, SIMULATION, SPECIALTIES, GUIDELINES AND RANDOMIZED CONTROLLED TRIALS (5-MINUTE TALKS)
Moderators:Mario Lachat, MD / Karl A. Illig, MD  
x
1:00 PM - 1:05 PM What’s New With Maintenance Of Certification (MOC) Requirements For Vascular Surgeons
  Presenter(s):Anton N. Sidawy, MD, MPH  
1:06 PM - 1:11 PM Recent Developments In The Evolution Of Vascular Training And Training Programs: Current Status Of The 0:5 Programs And Number Of Vascular Surgery Applicants And Spots
  Presenter(s):Karl A. Illig, MD  
1:12 PM - 1:17 PM How To Redesign Workflow To Improve Patient Care And Resident Training
  Presenter(s):Richard J. Powell, MD  
1:18 PM - 1:23 PM Advantages Of Case Specific Simulator Rehearsal With Endovascular Procedures
  Presenter(s):Isabelle Van Herzeele, MD, PhD  
1:24 PM - 1:29 PM What’s New And Better With The Pontresina Vascular Surgery Simulator Course For Trainees
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
1:30 PM - 1:35 PM Guidelines Are Outdated By The Time They Are Published: Some Examples
  Presenter(s):Janet T. Powell, MD, PhD  
1:36 PM - 1:41 PM Randomized Controlled Trials Can Be Misleading Even When Reported In Leading Journals: Guidelines Based On These Trials Can Also Be Misleading
  Presenter(s):Frank J. Veith, MD  
1:42 PM - 1:47 PM Advantages And Limitatons Of The OVATION Endograft (TriVascular) For AAA Repair: Based On The 1-Year Global Experience
  Presenter(s):Manish Mehta, MD, MPH  
1:48 PM - 1:53 PM Cost Effectiveness Of Different Treatment Strategies For CLI With Gangrene Or Necrosis
  Presenter(s):Michael Belkin, MD  
  View Abstract      
1:54 PM - 2:00 PM Panel Discussion
END OF SESSION 46
 
SESSION 47 SCHEDULE
Saturday
SESSION 47: MORE ABOUT HEALTH CARE REFORM, FDA, ETHICS, COSTS, STANDARDS AND GUIDELINES (5-MINUTE TALKS)
x
2:00 PM - 2:05 PM Impact Of Obamacare On Medicine In The US
  Presenter(s):Clifford J. Buckley, MD / Shirley Buckley, RN  
2:06 PM - 2:11 PM Why The Canadian Health Care System Works Better Than Obamacare Will
  Presenter(s):Dheeraj Rajan, MD, FRCPC  
  View Abstract      
2:12 PM - 2:17 PM How Should Aviation Training Serve As A Model For Educating Vascular Surgeons
  Presenter(s):John F. Eidt, MD  
2:18 PM - 2:23 PM What Has And Will The FDA Do To Medical Innovation In The US: An FDA Consultant’s Perspective: Will Things Improve
  Presenter(s):Thomas J. Fogarty, MD  
2:24 PM - 2:29 PM What Is The FDA Doing To Help The US Device Industry Be More Competitive: Is It Working
  Presenter(s):Dorothy B. Abel, BSBME / Kenneth J. Cavanaugh, Jr., PhD  
2:30 PM - 2:35 PM How To Get A Physician-Sponsored IDE: Tips And Tricks
  Presenter(s):Benjamin W. Starnes, MD  
2:36 PM - 2:41 PM Advantages Of The ESVS (European Society For Vascular Surgery) Guidelines For Vascular Surgery: Some Examples As To Why They Are Better Than US Guidelines
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
2:42 PM - 2:47 PM Current State Of The SVS Vascular Quality Initiative: Is It Growing And Is It Working
  Presenter(s):Jack L. Cronenwett, MD  
2:48 PM - 2:53 PM Vascular Quality Initiatives: A Dark Cloud Behind A Silver Lining: What Are Some Of The Problems And How Can They Be Resolved
  Presenter(s):Scott L. Stevens, MD  
2:54 PM - 3:10 PM Panel Discussion And Break
Visit Pavilions and Exhibits (2nd and 3rd Floors). EXHIBITS CLOSE AT 3:15 P.M.
END OF SESSION 47
 
SESSION 48 SCHEDULE
Saturday
SESSION 48: VASCULAR DISEASE NATURAL HISTORY; MEDICAL TREATMENT; PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
x
3:10 PM - 3:15 PM New Developments In Anticoagulant Drugs For Vascular Patients
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Abstract      
3:16 PM - 3:21 PM Decision Making Tool For Determining Which CLI Treatment Is Best: Open vs. Endovascular
  Presenter(s):Darren B. Schneider, MD  
3:22 PM - 3:27 PM Ongoing Developments In Drug Treatment Of Vascular Disease: Do HDL Raising Drugs Show Promise For Preventing Strokes And MIs
  Presenter(s):Michael R. Jaff, DO / Ron Waksman, MD / Ido Weinberg, MD, MSc  
3:28 PM - 3:33 PM Role Of Optimal Medical Treatment In Stroke Prevention: Does It Really Work
  Presenter(s):Michael R. Jaff, DO / Ido Weinberg, MD, MSc  
3:34 PM - 3:39 PM DEBATE: The Truth About Statin Toxicity: Has It Been Overplayed By The FDA And By The Media
  Presenter(s):Bruce A. Perler, MD, MBA  
3:40 PM - 3:45 PM DEBATE: Statins May Be Harmful And Should Be Used Less
  Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC  
3:46 PM - 3:51 PM How Should We Interpret The JUPITER Trial Showing The Value Of Statins: Has JUPITER Gotten A Bum Rap?
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
3:52 PM - 3:57 PM Do L-Arginine Supplements Help Vascular Patients: When And How Should They Be Given
  Presenter(s):Vikram S. Kashyap, MD  
  View Abstract      
3:58 PM - 4:03 PM Carotid Glomectomy Is A Good Treatment For Syncopal Vasophlegia: How To Do It
  Presenter(s):Erik E. Debing, MD, PhD  
  View Abstract      
4:04 PM - 4:09 PM Interactive Telephone Program To Allow Daily Monitoring Of Vascular Patients
  Presenter(s):John (Jeb) W. Hallett, MD  
4:10 PM - 4:15 PM Comparative Performance Of Rotorex And Angiojet For Clot Removal From Lower Extremity Arteries: Advantages And Limitations Of Each
  Presenter(s):Hermann Steinkamp, MD  
4:16 PM - 4:21 PM A New Device To Treat Resistant Hypertension By Carotid Baroreceptor Stimulation: The BAROSTIM Trial
  Presenter(s):Fred A. Weaver, MD  
  View Abstract      
4:22 PM - 4:29 PM Routine Use Of Ultrasound Guidance And Micropuncture Makes Endovascular Access Safer: How To Do It
  Presenter(s):Peter A. Schneider, MD  
  View Abstract      
4:30 PM - 4:37 PM Panel Discussion
END OF SESSION 48
 
SESSION 49 SCHEDULE
Saturday
SESSION 49: NEW TECHNIQUES; NEW CONCEPTS (5-MINUTE TALKS)
x
4:38 PM - 4:43 PM Laparoscopic Treatment Of The Arcuate Ligament Syndrome: Technique, Indications And Results
  Presenter(s):Yves Alimi, MD  
4:44 PM - 4:49 PM Is There Still A Place For Unilateral And Even Bilateral Hypogastric Embolization In 2012: How Safe Is It
  Presenter(s):Dieter Raithel, MD, PhD  
  View Abstract      
4:50 PM - 4:55 PM Hypogastric Preservation In Patients With Common Iliac Aneurysms Using Off-The-Shelf Devices
  Presenter(s):Karthikeshwar Kasirajan, MD  
4:56 PM - 5:01 PM Unusual Causes Of Upper Extremity Arterial Occlusive Disease
  Presenter(s):Kenneth J. Cherry, MD  
5:02 PM - 5:07 PM Catheter Directed Prostaglandins Are An Effective Treatment For CLI: As The Sole Treatment Or As An Adjunct To Other Endovascular Therapy
  Presenter(s):Oscar L. Ojeda, MD / Marcelo Patero, MD  
  View Abstract      
5:08 PM - 5:13 PM Carotid Interventions For Acute Stroke: When Are They Worthwhile And When Are They Not
  Presenter(s):R. Clement Darling III, MD  
  View Abstract      
5:14 PM - 5:19 PM How Do Pericardial Patches Heal And Why Are They Likely To Resist Infection
  Presenter(s):Alan Dardik, MD, PhD  
5:20 PM - 5:25 PM Imaging And Endovascular Techniques In The Removal Of Transvenous Pacer And ICD Leads
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Abstract      
5:26 PM - 5:31 PM Update On Treatment Of Infected Abdominal And Thoracic Endografts: Is It A Solvable Or Hopeless Problem And Is Non-Excisional Treatment Ever Successful
  Presenter(s):Peter R. Taylor, MA, MChir, FRCS, ARCM  
  View Abstract      
5:32 PM - 5:37 PM Non-Atherosclerotic Aortic Thrombosis: Causes, Diagnosis And Treatment
  Presenter(s):Cynthia K. Shortell, MD  
  View Abstract      
5:38 PM - 5:43 PM The SoloPath Expandable Introducer Sheath: How Does It Work And How Can It Be Helpful In EVAR Procedures
  Presenter(s):Jeffrey P. Carpenter, MD  
5:44 PM - 5:49 PM Management Of Infected CEA Patches: A 10-Year Experience
  Presenter(s):Ali F. AbuRahma, MD  
  View Abstract      
5:50 PM - 5:55 PM In Situ Fenestration For Left Subclavian Revascularization During TEVAR Is Safer And Better Than Carotid Subclavian Bypass: How To Do It
  Presenter(s):Frank R. Arko, MD  
5:56 PM - 6:01 PM Bell Bottom Iliac Limbs Have A Downside
  Presenter(s):Gustavo S. Oderich, MD, FACS  
6:02 PM - 6:10 PM Panel Discussion
END OF SESSION 49
 
SESSION 50 SCHEDULE
Saturday
SESSION 50: UPDATES, NEW TECHNOLOGY, NEW CONCEPTS (5-MINUTE TALKS)
x
3:10 PM - 3:15 PM Current Optimal Treatment Of Atrial Fibrillation In Vascular Patients
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
3:16 PM - 3:21 PM Prevalence Of Carotid Stenosis Varies According To Race: Highest In Caucasians And Native Americans
  Presenter(s):Caron B. Rockman, MD  
3:22 PM - 3:27 PM Ehrlos-Danlos Patients Can Have Endovascular Procedures Performed Safely: What Precautions Are Needed
  Presenter(s):James H. Black III, MD  
3:28 PM - 3:33 PM Bioabsorbable Scaffolds (REMEDY Stent), DEBs And DESs, In The SFA: What Is Their Future
  Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
3:34 PM - 3:39 PM Can The Achilles Tendon Be Excised Safely And With Minimal Disability To Treat Bad Heel Wounds And Plantar Pedal Ulcers
  Presenter(s):Wayne Caputo, DPM / Clifford M. Sales, MD, MBA  
3:40 PM - 3:45 PM Drug Eluting Balloon Evaluation For Lower Limb Multilevel Treatment – DEBELLUM Trial: 1-Year Results
  Presenter(s):Fabrizio Fanelli, MD / Plinio Rossi, MD  
3:46 PM - 3:51 PM Bypasses For Hand Digital Ischemia: What Is Their Role And Their Results
  Presenter(s):R. Clement Darling III, MD  
  View Abstract      
3:52 PM - 3:57 PM Retrohepatic Balloon Occlusion Of The IVC For Trauma And Renal Cell Cancer: How To Do It With Current Technology
  Presenter(s):Joseph S. Giglia, MD  
3:58 PM - 4:03 PM Carotid-To-Axillary Bypass Is Useful As A Debranching Technique And Easier And Less Risky Than Carotid-To-Subclavian Bypass
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
4:04 PM - 4:09 PM VIATORR Covered Stent For Early TIPS And Its Effect On Hepatic Encephalopathy And Ascites: Other New Horizons In TIPS
  Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR  
4:10 PM - 4:15 PM Which Post EVAR Patients Need Minimal Follow-up Surveillance: What Should That Consist Of
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
4:16 PM - 4:21 PM Angioslide Angioplasty Balloon With Embolic Capture (Proteus Device): When To Use It And Evidence Of Effectiveness
  Presenter(s):Peter C.J. Goverde, MD  
4:22 PM - 4:27 PM Outcomes Of Endovascular Treatment Of Lower Extremity Lesions Are Worse In Young Patients (<50)
  Presenter(s):Rabih A. Chaer, MD  
4:28 PM - 4:34 PM Panel Discussion
END OF SESSION 50
 
SESSION 51 SCHEDULE
Saturday
SESSION 51: MORE NEW CONCEPTS, UPDATES AND NEW TECHNIQUES (5-MINUTE TALKS)
x
4:34 PM - 4:39 PM Limitations Of A Large Palmaz Stent For Treating Type I Endoleaks
  Presenter(s):Tilo Koelbel, MD, PhD  
4:40 PM - 4:45 PM Recent Volumetric Analyses Of Post EVAR AAA Sac Behavior: Is Sac Enlargement Still A Concern
  Presenter(s):Mark F. Fillinger, MD  
4:46 PM - 4:51 PM 2-Stage Treatment For Aorto-Enteric Fistulas Following Aortic Reconstruction: A New Better Way
  Presenter(s):Gioacchino Coppi, MD  
4:52 PM - 4:57 PM Siena Score For Evaluating AAAs Suitability For EVAR: What Is It And How Does It Help
  Presenter(s):Francesco Setacci, MD  
  View Abstract      
4:58 PM - 5:03 PM Advantages And Early Results Of The ALTURA Ultra Low Profile AAA Endograft
  Presenter(s):Albrecht H. Kramer, MD  
5:04 PM - 5:09 PM Fascial Suture To Close Large Percutaneous Sheath Insertion Sites Cheaply And Effectively (The Larzon Technique): Tips And Tricks
  Presenter(s):Timothy A. Resch, MD, PhD  
5:10 PM - 5:15 PM Cost Per Day Of Patency In Endo vs. Open Lower Extremity Revascularization Procedures
  Presenter(s):Manish Mehta, MD, MPH  
5:16 PM - 5:21 PM Current Status Of Silver Impregnated Grafts To Treat Aortic Infection: Are We In The US Being Denied A Valuable Treatment Adjunct
  Presenter(s):Max Zegelman, MD, PhD  
  View Abstract      
5:22 PM - 5:27 PM Antibiotic Drug Delivery Implants Facilitates Treatment Of Some Infected Vascular Prosthetic Grafts
  Presenter(s):Dennis F. Bandyk, MD  
5:28 PM - 5:33 PM DW-MRI Based Evidence That Interruption Of Flow Embolic Protection With The MoMa Device Is Effective During CAS (The DESERVE Trial)
  Presenter(s):Giancarlo Biamino, MD, PhD  
5:34 PM - 5:39 PM Optimal Current Use Of Anticoagulants And Antiplatelet Drugs In Patients Undergoing CEA
  Presenter(s):Timothy M. Sullivan, MD  
5:40 PM - 5:45 PM Causes And Implications Of 30-Day Readmissions After AAA Repair: Endo And Open
  Presenter(s):K. Craig Kent, MD  
5:46 PM - 5:51 PM BASIL Survival Prediction Model In Patients With CLI: Validation And Comparison With PREVENT And FINNUVASC Scores
  Presenter(s):Robert J. Hinchliffe, MD  
5:52 PM - 5:57 PM Importance Of Pressure Gradients In Assessing Hemodynamic Significant Vascular Lesions: A Simple Method To Measure Them
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
5:58 PM - 6:05 PM Panel Discussion
END OF SESSION 51